Mortality News and Research

RSS

Quick, inexpensive leptospirosis test strip kit to help lower death and disability risk

The Faculty of Medicine, Chulalongkorn University has brought out a quick, inexpensive, and easy-to-use leptospirosis test strip kit to help lower the risk of disability from internal organ failure and death, with the hopes of distributing them to community hospitals across the country.

14 Aug 2021

Study exposes the dire need for new clinical risk management tools to prevent COVID-19 deaths

A new study exposes the dire need for new clinical risk management tools to help hospital healthcare workers prevent the deaths and intensive care admissions of Black, Asian and minority ethnic (BAME) COVID-19 patients with pneumonia, say researchers.

13 Aug 2021

Study finds durable responses to immunotherapy in rare angiosarcomas

In a small study of 16 patients with the rare cancer angiosarcoma, tumors in four patients partially or completely responded to treatment with a combination of the immunotherapy drugs ipilimumab and nivolumab.

13 Aug 2021

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

Although the world is focused on the COVID-19 pandemic, there are many other dangerous pathogens still out there, like Yersinia pestis, which causes plague – the deadly disease that killed tens of millions of people during the infamous Black Death in the 14th century.

13 Aug 2021

Yale perspective highlights new breakthrough therapies to treat non-small cell lung cancer

A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC).

12 Aug 2021

Study finds four circulating miRNAs which could effectively inhibit SARS-CoV-2 replication

In a new study, Chen-Yu Zhang's group from Nanjing University presents a rather striking finding that four circulating miRNAs, which are high in healthy people and much lower in older people and diabetic patients, could effectively inhibit SARS-CoV-2 replication by directly targeting the S protein.

12 Aug 2021

Link between high-fat diet, gut microbiota and cardiovascular disease revealed

A high-fat diet disrupts the biology of the gut's inner lining and its microbial communities -; and promotes the production of a metabolite that may contribute to heart disease, according to a study published Aug. 13 in the journal Science.

12 Aug 2021

Racial and ethnic disparities in maternal deaths in the U.S. may be larger than previously reported

Racial and ethnic disparities in maternal mortality — deaths related to pregnancy or childbirth — in the United States may be larger than previously reported, suggests a study funded by the National Institutes of Health.

12 Aug 2021

COVID-19 risks likely to shift from older adults to younger children

Within the next few years, as the SARS-CoV-2 virus becomes endemic in the global population, COVID-19 may behave like other common-cold coronaviruses, affecting mostly young children who have not yet been vaccinated or exposed to the virus, according to new modeling results.

11 Aug 2021

Researchers quantify left-over COVID vaccine in used Pfizer-BioNTech vials

A new observational study, published on medRxiv* preprint server, has evaluated the unused residual Pfizer-BioNTech vaccine in vials. Bainbridge Prepares (BP), an organization consisting of community medical and non-medical volunteers, supported the research.

11 Aug 2021

Norwegian study on the benefits of COVID vaccination for residents and employees in nursing homes

It is important to understand the vaccine effectiveness (VE) to determine how much protection it offers to the general population. Unfortunately, only a few studies are available that have determined the effect of the COVID-19 vaccine among the residents of LTCFs.

11 Aug 2021

Risk factors for hospitalization among HIV patients infected with SARS-CoV-2

The hospitalization of PWH with COVID-19 is related to host factors such as older age and co-morbidities, rather than due to traditional metrics of HIV.

11 Aug 2021

Analysis finds stable or decreasing trends in cervical cancer incidence and mortality

A recent trend analysis indicates that cervical cancer incidence and mortality rates have remained stable or are dropping in most countries across the globe.

11 Aug 2021

Emerging biosensing technologies could revolutionize the diagnosis of neonatal sepsis

Sepsis in newborn infants can be fatal. Early diagnosis is thus key to effectively manage the infection. Conventional diagnostic methods are, however, time-consuming.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A new study explores the polyclonal antibody response to SARS-CoV-2 in greater detail.

10 Aug 2021

Antiviral activity of lipid-modified remdesivir in comparison to common remdesivir

In new research, scientists evaluated the broad-spectrum antiviral activity of ODBG-P-RVn, an orally available, lipid-modified monophosphate prodrug of the remdesivir parent nucleoside (GS-441524) against viruses that cause diseases of human public health concern, including SARS-CoV-2.

10 Aug 2021

SARS-CoV-2 Iota variant increases mortality risk among older adults

The findings reveal that the variant has considerably higher transmissibility and immune escape potential than previously circulating variants and that it can increase the infection fatality rate by 62% - 82% among older adults. The study is currently available on the medRxiv* preprint server.

10 Aug 2021

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

A recent study in Colorado used real-world data to evaluate if individuals with chronic conditions have reduced antibody response to COVID-19 mRNA vaccines. The study investigated whether some medical conditions may impact antibody response to the mRNA vaccines.

9 Aug 2021

Mortality News and Research

Quick, inexpensive leptospirosis test strip kit to help lower death and disability risk

Study exposes the dire need for new clinical risk management tools to prevent COVID-19 deaths

Study finds durable responses to immunotherapy in rare angiosarcomas

Scientists document person-to-person transmission of antimicrobial-resistant pneumonic plague

Yale perspective highlights new breakthrough therapies to treat non-small cell lung cancer

Study finds four circulating miRNAs which could effectively inhibit SARS-CoV-2 replication

Link between high-fat diet, gut microbiota and cardiovascular disease revealed

Racial and ethnic disparities in maternal deaths in the U.S. may be larger than previously reported

COVID-19 risks likely to shift from older adults to younger children

Researchers quantify left-over COVID vaccine in used Pfizer-BioNTech vials

Norwegian study on the benefits of COVID vaccination for residents and employees in nursing homes

Risk factors for hospitalization among HIV patients infected with SARS-CoV-2

Analysis finds stable or decreasing trends in cervical cancer incidence and mortality

Emerging biosensing technologies could revolutionize the diagnosis of neonatal sepsis

COVID-19 vaccines offer better protection than natural immunity alone

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Antiviral activity of lipid-modified remdesivir in comparison to common remdesivir

SARS-CoV-2 Iota variant increases mortality risk among older adults

Study shows impaired SARS-CoV-2 mRNA vaccine antibody response in individuals with chronic conditions

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News